Serotonin uptake to lymphocytes of patients with social phobia compared to normal individuals

European Neuropsychopharmacology

Volumn 16, Issue 1, 2006, Pages 19-23

  Barkan, Tal ^a   Hermesh, Haggai ^a   Marom, Sofi ^a   Gurwitz, David ^a   Weizman, Abraham ^a   Rehavi, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Lymphocytes; Serotonin; Serotonin transporter; Social phobia

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG UPTAKE; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RECEPTOR AFFINITY; SAMPLE SIZE; SEROTONIN RELEASE; SOCIAL PHOBIA; TREATMENT INDICATION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LYMPHOCYTES; MALE; PHOBIC DISORDERS; SEROTONIN; SEVERITY OF ILLNESS INDEX; TRITIUM;

EID: 29344434944     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.06.002     Document Type: Article

References (38)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Press Washington, DC 416 417
2. T. Barkan, D. Gurwitz, G. Levy, A. Weizman, and M. Rehavi Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes Eur. Neuropsychopharmacol. 14 2004 237 243
3. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, and J. Erbaugh An inventory for measuring depression Arch. Gen. Psychiatry 4 1961 561 571
4. C. Bouwer, and D.J. Stein Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia J. Affect. Disord. 49 1998 79 82
5. K. Brady, T. Pearlstein, G.M. Asnis, D. Baker, B. Rothbaum, C.R. Sikes, and G.M. Farfel Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial JAMA 283 2000 1837 1844
6. S. Chatterjee, T.A. Sunitha, A. Velayudhan, and S. Khanna An investigation into the psychobiology of social phobia: personality domains and serotonin function Acta Psychiatr. Scand. 95 1997 544 550
7. R.M. Condren, T.G. Dinan, and J.H. Thakore A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity? Eur. Neuropsychopharmacol. 12 2002 349 354
8. K.M. Connor, S.M. Sutherland, L.A. Tupler, M.L. Malik, and J.R. Davidson Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study Br. J. Psychiatry 75 1999 17 22
9. J.R. Davidson, B.O. Rothbaum, B.A. van der Kolk, C.R. Sikes, and G.M. Farfel Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder Arch. Gen. Psychiatry 58 2001 485 492
10. K.M. Dewar, and A. Stravynski The quest for biological correlates of social phobia: an interim assessment Acta Psychiatr. Scand. 103 2001 244 251
11. M.B. First, R.L. Spitzer, M. Gibbon, and J. Williams Structured Clinical Interview for DMS-IV Axis I Disorders (SCID), Clinical Version: User's Guide 1996 American Psychiatric Press Washington, DC
12. W. Guy Clinical global impression severity scale ECDEU Assessment Manual for Psychopharmacology 1976 National Institutes of Mental Health Bethesda, MA
13. E. Hollander, J. Kwon, F. Weiller, L. Cohen, D.J. Stein, C. DeCaria, M. Liebowitz, and D. Simeon Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects Psychiatry Res. 79 1998 213 217
14. D.J. Katzelnick, K.A. Kobak, J.H. Greist, J.W. Jefferson, J.M. Mantle, and R.C. Serlin Sertraline for social phobia: a double-blind, placebo-controlled crossover study Am. J. Psychiatry 152 1995 1368 1371
15. J.B. Levin, S. Marom, S. Gur, D. Wechter, and H. Hermesh Psychometric properties and three proposed subscales of a self-report version of the Liebowitz Social Anxiety Scale translated into Hebrew Depress. Anxiety 16 2002 143 151
16. M.R. Liebowitz Social phobia Mod. Probl. Pharmacopsychiatry 22 1987 141 173
17. M.R. Liebowitz, F.R. Schneier, E. Hollander, L.A. Welkowitz, J.B. Saoud, J. Feerick, R. Campeas, B.A. Fallon, L. Street, and A. Gitow Treatment of social phobia with drugs other than benzodiazepines J. Clin. Psychiatry 52 1991 10 15 (Suppl)
18. M.R. Liebowitz, A.J. Gelenberg, and D. Munjack Venlafaxine extended release vs. placebo and paroxetine in social anxiety disorder Arch. Gen. Psychiatry 62 2005 190 198
19. M. Linnoila, M. Virkkunen, M. Scheinin, A. Nuutila, R. Rimon, and F.K. Goodwin Low cerebrospinal fluid 5-hydroxyindolacetic acid concentration differentiates impulsive from non-impulsive violent behavior Life Sci. 33 1983 2609 2614
20. M. Linnoila, M. Virkkunen, and A. Roy Biochemical aspects of aggression in man Clin. Neuropharmacol. 9 Suppl. 4 1986 377 379
21. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurements with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
22. R.B. Lydiard The role of drug therapy in social phobia J. Affect. Disord. 50 Suppl. 1 1998 S35 S39
23. I.M. McIntyre, F.K. Judd, G.D. Burrows, and T.R. Norman Serotonin in panic disorder: platelet uptake and concentration Int. Clin. Psychopharmacol. 4 1989 1 6
24. P.T. Mehlman, J.D. Higley, I. Faucher, A.A. Lilly, D.M. Taub, J. Vickers, S.J. Suomi, and M. Linnoila Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates Am. J. Psychiatry 152 1995 907 913
25. M.J. Raleigh, M.T. McGuire, G.L. Brammer, and A. Yuwiler Social and environmental influences on blood serotonin concentrations in monkeys Arch. Gen. Psychiatry 41 1984 405 410
26. M.J. Raleigh, M.T. McGuire, G.L. Brammer, D.B. Pollack, and A. Yuwiler Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys Brain Res. 559 1991 181 190
27. D.A. Regier, C.T. Kaelber, D.S. Rae, M.E. Farmer, B. Knauper, R.C. Kessler, and G.S. Norquist Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy Arch. Gen. Psychiatry 55 1998 109 115
28. D. Sheehan The Anxiety Disease 1983 Scribner New York 148 149
29. M.B. Stein Neurobiological perspectives on social phobia: from affiliation to zoology Biol. Psychiatry 44 1998 1277 1285
30. 3H]Paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers Biol. Psychiatry 37 1995 224 228
31. M.B. Stein, M.R. Liebowitz, R.B. Lydiard, C.D. Pitts, W. Bushnell, and I. Gergel Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial JAMA 280 1998 708 713
32. M.B. Stein, A.J. Fyer, J.R. Davidson, M.H. Pollack, and B. Wiita Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study Am. J. Psychiatry 156 1999 756 760
33. M.B. Stein, M.H. Pollack, A. Bystritsky, J.E. Kelsey, and R.M. Mangano Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial Psychopharmcology 177 2005 280 288
34. M.E. Tancer Neurobiology of social phobia J. Clin. Psychiatry 54 1993 26 30 (Suppl.)
35. M.E. Tancer, R.B. Mailman, M.B. Stein, G.A. Mason, S.W. Carson, and R.N. Golden Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia Anxiety 1 1994 216 223
36. M.A. Van Ameringen, R.M. Lane, J.R. Walker, R.C. Bowen, P.R. Chokka, E.M. Goldner, D.G. Johnston, Y.J. Lavallee, S. Nandy, J.C. Pecknold, V. Hadrava, and R.P. Swinson Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study Am. J. Psychiatry 158 2001 275 281
37. B.A. Van der Kolk, D. Dreyfuss, M. Michaels, D. Shera, R. Berkowitz, R. Fisler, and G. Saxe Fluoxetine in posttraumatic stress disorder J. Clin. Psychiatry 55 1994 517 522
38. I.M. Van Vliet, J.A. den Boer, and H.G. Westenberg Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine Psychopharmacology (Berl.) 115 1994 128 134